Trial initiated for long-lasting injectable PrEP to block HIV transmission
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
The first phase 3 clinical trial of a long-acting injectable drug to block transmission of…
Researchers at the University of North Carolina (UNC) School of Medicine are conducting studies that…